Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FTCES
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,054
Award facts
- Contract value 100% obligated
- $5,054.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units, with a ceiling value of $5,054.30. This award represents a firm fixed price delivery order with an ultimate completion date of November 3, 2025. The contract was competitively awarded without set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This specific delivery order for DESCOVY, an antiretroviral medication, reflects the company's role in supplying essential pharmaceutical commodities to support military healthcare programs globally. The competitive award of this order, consistent with AmerisourceBergen's established track record with DLA, underscores the company's continued qualification to fulfill federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DB26FTCES?
SPE2DB26FTCES was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FTCES worth?
The government has obligated $5,054 on SPE2DB26FTCES.
Is contract SPE2DB26FTCES an order under another contract?
Yes. SPE2DB26FTCES is a delivery order under SPE2DB25D3110, an indefinite delivery contract.
Was contract SPE2DB26FTCES competed?
The extent of competition for SPE2DB26FTCES was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award